Can Surgeons Improve Survival in Stage IV Melanoma?
Successful systemic management of stage IV melanoma continues to be elusive because of the paucity of effective therapies. This has fueled the continued interest in surgical resection. Several single-institution studies and a current, large, multi-institutional phase III trial have demonstrated a survival benefit for patients who underwent surgical resection for melanoma metastases. Incorporating these results into new approaches using multimodality treatment may enhance survival in patients with stage IV melanoma.
Published In/Presented At
Mosca, P. J., Teicher, E., Nair, S. P., & Pockaj, B. A. (2008). Can surgeons improve survival in stage IV melanoma?.Journal Of Surgical Oncology, 97(5), 462-468. doi:10.1002/jso.20950
Hematology | Medical Sciences | Medicine and Health Sciences | Oncology
Peer Reviewed for front end display
Department of Medicine, Hematology-Medical Oncology Division, Department of Medicine Faculty